Expression of inflammatory lipopolysaccharide binding protein (LBP) predicts the progression of conventional renal cell carcinoma-a short report

G Kovacs, L Peterfi, N Farkas, A Javorhazy, C Pusztai… - Cellular Oncology, 2017 - Springer
Background The mortality of conventional renal cell carcinoma (RCC) correlates directly with
the presence or postoperative development of metastases. The aim of this study was to …

Biomarkers of renal cancer

NS Vasudev, RE Banks - Biomarkers of Kidney Disease, 2017 - Elsevier
Renal cell carcinoma (RCC) presents many challenges to the treating physician which
biomarkers are ideally placed to address. No circulating markers are in routine clinical use …

Cerca i identificació de nous biomarcadors de fibrosi hepàtica per mitjà de tècniques proteòmiques

S Marfà Bruix - 2017 - diposit.ub.edu
[cat] La detecció precoç de fibrosi hepàtica és de gran rellevància per al diagnòstic i el
tractament dels pacients amb una malaltia hepàtica crònica. Actualment, s' utilitzen diversos …

Renal Cell Carcinoma Biomarkers in Circulation

GD Dakubo, GD Dakubo - Cancer Biomarkers in Body Fluids: Biomarkers …, 2017 - Springer
Molecular pathology of renal cell carcinoma (RCC) Circulating cell-free nucleic acid content
as RCC biomarkers Circulating RCC miRNA biomarkers Circulating cytokine and …

[PDF][PDF] Új biomarkerek a konvencionális veserák progressziójának megítélésére

J András - 2017 - pea.lib.pte.hu
Renal cell carcinoma (RCC) represents 2-3% of all cancers occurring with the highest
incidence in Western countries. In 2012 approximately 84.000 patients were diagnosed with …

[引用][C] Serum Amyloid A Protein levels in Neonatal Sepsis

P Krishnavenil, V Gowda - International Journal of Clinical Biochemistry and …, 2017

[引用][C] Új biomarkerek a konvencionális veserák progressziójának megítélésére

U Klinika, F László